Baseless opposition to GM Mustard: ABLE-AG

The premier agribiotech association has alleged that few groups are baselessly opposing the approval of GM Mustard, currently under review by the Genetic Engineering Approval Committee (GEAC)


As per Dr Shivendra Bajaj, executive director, Association of Biotech Led Enterprises- Agriculture Focus Group (ABLE-AG), "GM Mustard has been submitted for approval to the apex review committee, Genetic Engineering Appraisal Committee (GEAC) after extensive research and trials which has been ongoing since the last 16 years, under the leadership of the renowned scientist of Delhi University, Dr Deepak Pental, and funded by Department of Biotechnology (DBT) and National Dairy Development Board's (NDDB).

"The protest by some of these ill-informed groups implies that they do not even want a scientific review of the research. All we are saying is that let GEAC make a decision. Protesting against a technology without letting the regulators review the efficacy and safety is not right. In any case, we would like to highlight that genetically modified food has been consumed for over two decades across the world and not even a single case of adverse effect has been reported," added Dr Bajaj.

Safety angle

On the question of safety, Dr Bajaj mentioned, "In India, the cotton seed oil from Bt cotton has been used for cooking, for several years. The whole world including us consumes soybean and Canola oil, most of which is derived from GM plants, without any objection. Then why this sudden protest about a technology that has been developed by an eminent scientist of global repute, who has dedicated most of his life in mustard improvement."

Yield benefit

From the yield perspective, Dr Bajaj elaborated, "GM Mustard hybrid has the potential of increasing yield by 25 per cent. There is a growing need for GM Mustard in the country. Last year, India imported around Rs. 65,000 crores of edible oils to meet its consumption requirements. With increase in the population and per capita incomes, this deficit will only increase and can be met only through higher productivity of oilseed crops. Dr Pental's group has carried out very extensive work on quality traits and disease resistance. Once the technology is deregulated, quality hybrids and more productive hybrids with disease resistance will be readily possible."


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email